{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:43:58Z","timestamp":1784925838136,"version":"3.55.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00210-024-03123-6","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:02:01Z","timestamp":1715061721000},"page":"7711-7724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment"],"prefix":"10.1007","volume":"397","author":[{"given":"Wenjia","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2019e","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingdi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"3123_CR1","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"JS Amberger","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A (2015) OMIM.org: Online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43:D789-798","journal-title":"Nucleic Acids Res"},{"key":"3123_CR2","doi-asserted-by":"crossref","unstructured":"Belinky F, Nativ N, Stelzer G, Zimmerman S, Iny Stein T, Safran M, Lancet D (2015) PathCards: multi-source consolidation of human biological pathways. Database (Oxford) 2015","DOI":"10.1093\/database\/bav006"},{"key":"3123_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2016.02.010","volume":"60","author":"VR Belum","year":"2016","unstructured":"Belum VR, Benhuri B, Postow MA, Hellmann MD, Lesokhin AM, Segal NH, Motzer RJ, Wu S, Busam KJ, Wolchok JD, Lacouture ME (2016) Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer 60:12\u201325","journal-title":"Eur J Cancer"},{"key":"3123_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nsb1203-980","volume":"10","author":"H Berman","year":"2003","unstructured":"Berman H, Henrick K, Nakamura H (2003) Announcing the worldwide Protein Data Bank. Nat Struct Biol 10:980","journal-title":"Nat Struct Biol"},{"key":"3123_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"3123_CR6","doi-asserted-by":"publisher","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","volume":"49","author":"SK Burley","year":"2021","unstructured":"Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, Christie CH, Dalenberg K, Di Costanzo L, Duarte JM, Dutta S, Feng Z, Ganesan S, Goodsell DS, Ghosh S, Green RK, Guranovic V, Guzenko D, Hudson BP, Lawson CL, Liang Y, Lowe R, Namkoong H, Peisach E, Persikova I, Randle C, Rose A, Rose Y, Sali A, Segura J, Sekharan M, Shao C, Tao YP, Voigt M, Westbrook JD, Young JY, Zardecki C, Zhuravleva M (2021) RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res 49:D437\u2013D451","journal-title":"Nucleic Acids Res"},{"key":"3123_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ (2021) Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (engl) 134:783\u2013791","journal-title":"Chin Med J (engl)"},{"key":"3123_CR8","doi-asserted-by":"crossref","unstructured":"Chakraborty E, Sarkar D (2022) Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers (Basel)\u00a014:2798","DOI":"10.3390\/cancers14112798"},{"key":"3123_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.809509","volume":"9","author":"S Chen","year":"2022","unstructured":"Chen S, Zhao Z, Wang X, Zhang Q, Lyu L, Tang B (2022) The predictive competing endogenous RNA regulatory networks and potential prognostic and immunological roles of cyclin A2 in pan-cancer analysis. Front Mol Biosci 9:809509","journal-title":"Front Mol Biosci"},{"key":"3123_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/bib\/bbv066","volume":"17","author":"X Chen","year":"2016","unstructured":"Chen X, Yan CC, Zhang X, Zhang X, Dai F, Yin J, Zhang Y (2016) Drug-target interaction prediction: databases, web servers and computational models. Brief Bioinform 17:696\u2013712","journal-title":"Brief Bioinform"},{"key":"3123_CR11","doi-asserted-by":"crossref","unstructured":"Chinyama HA, Wei L, Mokgautsi N, Lawal B, Wu ATH, Huang HS (2023) Identification of CDK1, PBK, and CHEK1 as an oncogenic signature in glioblastoma: a bioinformatics approach to repurpose dapagliflozin as a therapeutic agent. Int J Mol Sci 24:16396","DOI":"10.3390\/ijms242216396"},{"key":"3123_CR12","doi-asserted-by":"publisher","first-page":"16226","DOI":"10.1038\/s41598-023-42801-y","volume":"13","author":"P Dai","year":"2023","unstructured":"Dai P, Xiong L, Wei Y, Wei X, Zhou X, Zhao J, Tang H (2023) A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors. Sci Rep 13:16226","journal-title":"Sci Rep"},{"key":"3123_CR13","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"A Daina","year":"2014","unstructured":"Daina A, Michielin O, Zoete V (2014) iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach. J Chem Inf Model 54:3284\u20133301","journal-title":"J Chem Inf Model"},{"key":"3123_CR14","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"key":"3123_CR15","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364","journal-title":"Nucleic Acids Res"},{"key":"3123_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nature03192","volume":"432","author":"CM Dobson","year":"2004","unstructured":"Dobson CM (2004) Chemical space and biology. Nature 432:824\u2013828","journal-title":"Nature"},{"key":"3123_CR17","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.4161\/15384047.2014.955728","volume":"15","author":"F Dong","year":"2014","unstructured":"Dong F, Zhou X, Li C, Yan S, Deng X, Cao Z, Li L, Tang B, Allen TD, Liu J (2014) Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis. Cancer Biol Ther 15:1479\u20131488","journal-title":"Cancer Biol Ther"},{"key":"3123_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth T (2017) From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 46:65\u201383","journal-title":"Semin Cancer Biol"},{"key":"3123_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ygyno.2011.10.022","volume":"124","author":"AA Garcia","year":"2012","unstructured":"Garcia AA, Sill MW, Lankes HA, Godwin AK, Mannel RS, Armstrong DK, Carolla RL, Liepman MK, Spirtos NM, Fischer EG, Leslie KK (2012) A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study. Gynecol Oncol 124:569\u2013574","journal-title":"Gynecol Oncol"},{"key":"3123_CR20","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","volume":"29","author":"D Gfeller","year":"2013","unstructured":"Gfeller D, Michielin O, Zoete V (2013) Shaping the interaction landscape of bioactive molecules. Bioinformatics 29:3073\u20133079","journal-title":"Bioinformatics"},{"key":"3123_CR21","doi-asserted-by":"crossref","unstructured":"Grignano E, Cantero-Aguilar L, Tuerdi Z, Chabane T, Vazquez R, Johnson N, Zerbit J, Decroocq J, Birsen R, Fontenay M, Kosmider O, Chapuis N, Bouscary D (2023) Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Cell Death Discov 9:97","DOI":"10.1038\/s41420-023-01371-8"},{"key":"3123_CR22","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/s41388-023-02694-7","volume":"42","author":"MV Guijarro","year":"2023","unstructured":"Guijarro MV, Nawab A, Dib P, Burkett S, Luo X, Feely M, Nasri E, Seifert RP, Kaye FJ, Zajac-Kaye M (2023) TYMS promotes genomic instability and tumor progression in Ink4a\/Arf null background. Oncogene 42:1926\u20131939","journal-title":"Oncogene"},{"key":"3123_CR23","doi-asserted-by":"publisher","first-page":"2764940","DOI":"10.1155\/2022\/2764940","volume":"2022","author":"X Guo","year":"2022","unstructured":"Guo X, Zhou L, Wu Y, Li J (2022) KIF11 as a potential pan-cancer immunological biomarker encompassing the disease staging, prognoses, tumor microenvironment, and therapeutic responses. Oxid Med Cell Longev 2022:2764940","journal-title":"Oxid Med Cell Longev"},{"key":"3123_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3736\/jcim20030315","volume":"1","author":"MQ Han","year":"2003","unstructured":"Han MQ, Su JM, Huang HY, Long WH, Qin LP, Qin P, Liu W, Sheng ZY (2003) Prognostic analysis of advanced non small cell lung cancer treated by sequential chemo-radiation therapy combined with traditional Chinese medicine: a report of 54 cases. Zhong Xi Yi Jie He Xue Bao 1:195\u2013198","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"3123_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature02555","volume":"430","author":"JD Han","year":"2004","unstructured":"Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430:88\u201393","journal-title":"Nature"},{"key":"3123_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3892\/ol.2021.12914","volume":"22","author":"L Hao","year":"2021","unstructured":"Hao L, Li S, Peng Q, Guo Y, Ji J, Zhang Z, Xue Y, Liu Y, Shi X (2021) Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer. Oncol Lett 22:653","journal-title":"Oncol Lett"},{"key":"3123_CR27","doi-asserted-by":"crossref","unstructured":"Hien TT, White NJ (1993) Qinghaosu. Lancet 341: 603-608","DOI":"10.1016\/0140-6736(93)90362-K"},{"key":"3123_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1574892817666220511162046","volume":"18","author":"CY Huang","year":"2023","unstructured":"Huang CY, Cheng YM, Li W, Huang YC, Luo H, Zhong C, Liu FB (2023) Examining the mechanisms of Huachansu injection on liver cancer through integrated bioinformatics analysis. Recent Pat Anticancer Drug Discov 18:408\u2013425","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"3123_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.lfs.2017.11.008","volume":"192","author":"E Im","year":"2018","unstructured":"Im E, Yeo C, Lee HJ, Lee EO (2018) Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells. Life Sci 192:286\u2013292","journal-title":"Life Sci"},{"key":"3123_CR30","doi-asserted-by":"publisher","first-page":"11845","DOI":"10.1080\/07391102.2022.2164056","volume":"41","author":"B Islam","year":"2023","unstructured":"Islam B, Yu HY, Duan TQ, Pan J, Li M, Zhang RQ, Masroor M, Huang JF (2023) Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC. J Biomol Struct Dyn 41:11845\u201311861","journal-title":"J Biomol Struct Dyn"},{"key":"3123_CR31","unstructured":"Jansen FH, Adoubi I, KC JC, Cnodder TDE, Jansen N, Tschulakow A, Efferth T (2011) First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res 31: 4417-4422"},{"key":"3123_CR32","doi-asserted-by":"publisher","first-page":"87271","DOI":"10.18632\/oncotarget.13536","volume":"7","author":"J Jiang","year":"2016","unstructured":"Jiang J, Geng G, Yu X, Liu H, Gao J, An H, Cai C, Li N, Shen D, Wu X, Zheng L, Mi Y, Yang S (2016) Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-kappaB\/GLUT1 axis. Oncotarget 7:87271\u201387283","journal-title":"Oncotarget"},{"key":"3123_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032693","volume":"102","author":"X Jiang","year":"2023","unstructured":"Jiang X, Zhou J, Yu Z, Gu X, Lu Y, Ruan Y, Wang T (2023) Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular docking. Medicine (Baltimore) 102:e32693","journal-title":"Medicine (Baltimore)"},{"key":"3123_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Zidek A, Potapenko A, Bridgland A, Meyer C, Kohl SAA, Ballard AJ, Cowie A, Romera-Paredes B, Nikolov S, Jain R, Adler J, Back T, Petersen S, Reiman D, Clancy E, Zielinski M, Steinegger M, Pacholska M, Berghammer T, Bodenstein S, Silver D, Vinyals O, Senior AW, Kavukcuoglu K, Kohli P, Hassabis D (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589","journal-title":"Nature"},{"key":"3123_CR35","doi-asserted-by":"publisher","first-page":"D354","DOI":"10.1093\/nar\/gkj102","volume":"34","author":"M Kanehisa","year":"2006","unstructured":"Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34:D354-357","journal-title":"Nucleic Acids Res"},{"key":"3123_CR36","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2023) PubChem 2023 update. Nucleic Acids Res 51:D1373\u2013D1380","journal-title":"Nucleic Acids Res"},{"key":"3123_CR37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049\u20131055","journal-title":"Science"},{"key":"3123_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","volume":"2","author":"S Krishna","year":"2015","unstructured":"Krishna S, Ganapathi S, Ster IC, Saeed ME, Cowan M, Finlayson C, Kovacsevics H, Jansen H, Kremsner PG, Efferth T, Kumar D (2015) A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer. EBioMedicine 2:82\u201390","journal-title":"EBioMedicine"},{"key":"3123_CR39","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/abbs\/gmy125","volume":"50","author":"B Li","year":"2018","unstructured":"Li B, Bu S, Sun J, Guo Y, Lai D (2018) Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest. Acta Biochim Biophys Sin (Shanghai) 50:1227\u20131235","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"3123_CR40","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2147\/OTT.S297785","volume":"14","author":"Q Li","year":"2021","unstructured":"Li Q, Ma Q, Cheng J, Zhou X, Pu W, Zhong X, Guo X (2021) Dihydroartemisinin as a sensitizing agent in cancer therapies. Onco Targets Ther 14:2563\u20132573","journal-title":"Onco Targets Ther"},{"key":"3123_CR41","first-page":"139","volume":"28","author":"T Liu","year":"2019","unstructured":"Liu T, Guo J, Wang T, Zhang S, Yu X, Hou C, Guo D (2019) Network pharmacology-based analysis of mechanisms of the anti-hepatocellular carcinoma effect by dihydroartemisinin. Discov Med 28:139\u2013147","journal-title":"Discov Med"},{"key":"3123_CR42","doi-asserted-by":"publisher","first-page":"W609","DOI":"10.1093\/nar\/gkq300","volume":"38","author":"X Liu","year":"2010","unstructured":"Liu X, Ouyang S, Yu B, Liu Y, Huang K, Gong J, Zheng S, Li Z, Li H, Jiang H (2010) PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res 38:W609-614","journal-title":"Nucleic Acids Res"},{"key":"3123_CR43","doi-asserted-by":"crossref","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6","DOI":"10.1038\/s41572-020-00240-3"},{"key":"3123_CR44","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41416-023-02468-8","volume":"129","author":"G Massacci","year":"2023","unstructured":"Massacci G, Perfetto L, Sacco F (2023) The Cyclin-dependent kinase 1: more than a cell cycle regulator. Brit J Cancer 129:1707\u20131716","journal-title":"Brit J Cancer"},{"key":"3123_CR45","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"3123_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1359-6349(10)71170-8","volume":"8","author":"T Ontikatze","year":"2010","unstructured":"Ontikatze T, Handrick R, Grimm F, Henke G, Daniel PT, Belka C, Jendrossek V (2010) Dihydroartemisinin is a hypoxia active anticancer drug. Ejc Suppl 8:94\u201394","journal-title":"Ejc Suppl"},{"key":"3123_CR47","doi-asserted-by":"publisher","first-page":"8755263","DOI":"10.1155\/2022\/8755263","volume":"2022","author":"X Pang","year":"2022","unstructured":"Pang X, Wan W, Wu X, Shen Y (2022) The novel action of miR-193b-3p\/CDK1 signaling in HCC proliferation and migration: a study based on bioinformatic analysis and experimental investigation. Int J Genomics 2022:8755263","journal-title":"Int J Genomics"},{"key":"3123_CR48","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/ptr.7695","volume":"37","author":"Q Peng","year":"2023","unstructured":"Peng Q, Li S, Shi X, Guo Y, Hao L, Zhang Z, Ji J, Zhao Y, Li C, Xue Y, Liu Y (2023) Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy. Phytother Res 37:1740\u20131753","journal-title":"Phytother Res"},{"key":"3123_CR49","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","volume":"19","author":"J Pinero","year":"2021","unstructured":"Pinero J, Sauch J, Sanz F, Furlong LI (2021) The DisGeNET cytoscape app: exploring and visualizing disease genomics data. Comput Struct Biotechnol J 19:2960\u20132967","journal-title":"Comput Struct Biotechnol J"},{"key":"3123_CR50","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072","journal-title":"J Med Chem"},{"key":"3123_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13","journal-title":"J Cheminform"},{"key":"3123_CR52","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1039\/D3CC00265A","volume":"59","author":"ML Ruan","year":"2023","unstructured":"Ruan ML, Liu Y, Zhang C, Mao X, Hu D, Lok CN, Yam JWP, Che CM (2023) Dihydroartemisinin engages liver fatty acid binding protein and suppresses metastatic hepatocellular carcinoma growth. Chem Commun (Camb) 59:2747\u20132750","journal-title":"Chem Commun (Camb)"},{"key":"3123_CR53","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77:1598\u20131606","journal-title":"J Hepatol"},{"key":"3123_CR54","doi-asserted-by":"crossref","unstructured":"Scott K, Hayden PJ, Will A, Wheatley K, Coyne I (2016) Bortezomib for the treatment of multiple myeloma. Cochrane Database Syst Rev 4: CD010816","DOI":"10.1002\/14651858.CD010816.pub2"},{"key":"3123_CR55","doi-asserted-by":"publisher","first-page":"1156062","DOI":"10.3389\/fmolb.2023.1156062","volume":"10","author":"H Shi","year":"2023","unstructured":"Shi H, Xiong L, Yan G, Du S, Liu J, Shi Y (2023) Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis. Front Mol Biosci 10:1156062","journal-title":"Front Mol Biosci"},{"key":"3123_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0024-3205(01)01372-8","volume":"70","author":"NP Singh","year":"2001","unstructured":"Singh NP, Lai H (2001) Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 70:49\u201356","journal-title":"Life Sci"},{"key":"3123_CR57","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ijrobp.2017.03.007","volume":"98","author":"K Sommat","year":"2017","unstructured":"Sommat K, Ong WS, Hussain A, Soong YL, Tan T, Wee J, Fong KW (2017) Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 98:574\u2013580","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3123_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/35038557","volume":"1","author":"BR Stockwell","year":"2000","unstructured":"Stockwell BR (2000) Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet 1:116\u2013125","journal-title":"Nat Rev Genet"},{"key":"3123_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/1076029609336857","volume":"16","author":"B Sun","year":"2010","unstructured":"Sun B, Luo M, Lu Z, Meng Y, Wu S, Wu M (2010) Clinical studies of laser ablation in treatment of primary liver carcinoma-associated portal vein tumor thrombus. Clin Appl Thromb Hemost 16:694\u2013697","journal-title":"Clin Appl Thromb Hemost"},{"key":"3123_CR60","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646","journal-title":"Nucleic Acids Res"},{"key":"3123_CR61","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"C UniProt","year":"2023","unstructured":"UniProt C (2023) UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res 51:D523\u2013D531","journal-title":"Nucleic Acids Res"},{"key":"3123_CR68","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","volume":"56","author":"X Wang","year":"2016","unstructured":"Wang X, Pan C, Gong J, Liu X, Li H (2016) Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs. J Chem Inf Model 56:1175\u20131183","journal-title":"J Chem Inf Model"},{"key":"3123_CR69","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, Lai L, Pei J, Li H (2017) PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res 45:W356\u2013W360","journal-title":"Nucleic Acids Res"},{"key":"3123_CR64","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029593","volume":"101","author":"T Wang","year":"2022","unstructured":"Wang T, Jiang X, Ruan Y, Li L, Chu L (2022a) The mechanism of action of the combination of Astragalus membranaceus and Ligusticum chuanxiong in the treatment of ischemic stroke based on network pharmacology and molecular docking. Medicine (Baltimore) 101:e29593","journal-title":"Medicine (Baltimore)"},{"key":"3123_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029762","volume":"101","author":"T Wang","year":"2022","unstructured":"Wang T, Zhou Y, Wang K, Jiang X, Wang J, Chen J (2022b) Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology. Medicine (Baltimore) 101:e29762","journal-title":"Medicine (Baltimore)"},{"key":"3123_CR70","doi-asserted-by":"publisher","first-page":"11161","DOI":"10.1038\/s41598-022-15205-7","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Wang J, Lyu L, Gao X, Cai Y, Tang B (2022c) Oncogenic role and potential regulatory mechanism of topoisomerase IIalpha in a pan-cancer analysis. Sci Rep 12:11161","journal-title":"Sci Rep"},{"key":"3123_CR62","doi-asserted-by":"publisher","first-page":"20220674","DOI":"10.1515\/biol-2022-0674","volume":"18","author":"F Wang","year":"2023","unstructured":"Wang F, Xiao C, Jia T, Pan L, Du F, Wang Z (2023a) Hepatobiliary surgery based on intelligent image segmentation technology. Open Life Sci 18:20220674","journal-title":"Open Life Sci"},{"key":"3123_CR63","first-page":"1543","volume":"15","author":"T Wang","year":"2023","unstructured":"Wang T, Jiang X, Lu Y, Ruan Y, Wang J (2023b) Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma. Aging (Albany NY) 15:1543\u20131563","journal-title":"Aging (Albany NY)"},{"key":"3123_CR65","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1186\/s13018-023-04417-w","volume":"18","author":"T Wang","year":"2023","unstructured":"Wang T, Wang J, Chen Y, Ruan Y, Dai S (2023c) Efficacy of aquatic exercise in chronic musculoskeletal disorders: a systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res 18:942","journal-title":"J Orthop Surg Res"},{"key":"3123_CR66","doi-asserted-by":"publisher","first-page":"13767","DOI":"10.1038\/s41598-023-41101-9","volume":"13","author":"T Wang","year":"2023","unstructured":"Wang T, Yin Y, Jiang X, Ruan Y, Xu J, Hu X, Li T, Chu L, Li L (2023d) Exploring the mechanism of luteolin by regulating microglia polarization based on network pharmacology and in vitro experiments. Sci Rep 13:13767","journal-title":"Sci Rep"},{"key":"3123_CR72","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/ddr.22067","volume":"84","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang Z, Zhu W, Chen Y, He X, Li J, Han Z, Yang Y, Liu W, Zhang K (2023e) Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT\/mTOR signaling. Drug Dev Res 84:988\u2013998","journal-title":"Drug Dev Res"},{"key":"3123_CR71","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037153","volume":"103","author":"X Wang","year":"2024","unstructured":"Wang X, Wang T, Jiang X, Ruan Y, Wang J, Qi C (2024) The potential mechanism of Guizhi Fuling Wan effect in the treatment of cervical squamous cell carcinoma: a bioinformatics analysis investigation. Medicine (Baltimore) 103:e37153","journal-title":"Medicine (Baltimore)"},{"key":"3123_CR73","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082","journal-title":"Nucleic Acids Res"},{"key":"3123_CR74","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.18632\/aging.203979","volume":"14","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Ma J, Guo C, Liu D, Pan J, Huang X (2022) Cyclin B2 overexpression promotes tumour growth by regulating jagged 1 in hepatocellular carcinoma. Aging (Albany NY) 14:2855\u20132867","journal-title":"Aging (Albany NY)"},{"key":"3123_CR75","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, Chen X, Hou T, Cao D (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49:W5\u2013W14","journal-title":"Nucleic Acids Res"},{"key":"3123_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","volume":"107","author":"CC Xu","year":"2016","unstructured":"Xu CC, Deng T, Fan ML, Lv WB, Liu JH, Yu BY (2016) Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives. Eur J Med Chem 107:192\u2013203","journal-title":"Eur J Med Chem"},{"key":"3123_CR77","doi-asserted-by":"publisher","first-page":"9528","DOI":"10.3892\/mmr.2017.7832","volume":"16","author":"CH Xu","year":"2017","unstructured":"Xu CH, Liu Y, Xiao LM, Guo CG, Zheng SY, Zeng EM, Li DH (2017) Dihydroartemisinin treatment exhibits antitumor effects in glioma cells through induction of apoptosis. Mol Med Rep 16:9528\u20139532","journal-title":"Mol Med Rep"},{"key":"3123_CR78","doi-asserted-by":"publisher","first-page":"1186101","DOI":"10.3389\/fonc.2023.1186101","volume":"13","author":"C Yang","year":"2023","unstructured":"Yang C, Plum PS, Gockel I, Thieme R (2023) Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers. Front Oncol 13:1186101","journal-title":"Front Oncol"},{"key":"3123_CR79","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"ZJ Yao","year":"2016","unstructured":"Yao ZJ, Dong J, Che YJ, Zhu MF, Wen M, Wang NN, Wang S, Lu AP, Cao DS (2016) TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models. J Comput Aided Mol Des 30:413\u2013424","journal-title":"J Comput Aided Mol Des"},{"key":"3123_CR80","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00268-017-4003-x","volume":"41","author":"T Yoshikawa","year":"2017","unstructured":"Yoshikawa T, Nomi T, Hokuto D, Yasuda S, Kawaguchi C, Yamada T, Kanehiro H, Nakajima Y (2017) Risk factors for postoperative ascites in patients undergoing liver resection for hepatocellular carcinoma. World J Surg 41:2095\u20132100","journal-title":"World J Surg"},{"key":"3123_CR81","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.bcp.2012.02.002","volume":"83","author":"CZ Zhang","year":"2012","unstructured":"Zhang CZ, Zhang H, Yun J, Chen GG, Lai PB (2012) Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol 83:1278\u20131289","journal-title":"Biochem Pharmacol"},{"key":"3123_CR82","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.18632\/aging.204369","volume":"14","author":"S Zheng","year":"2022","unstructured":"Zheng S, Pan B (2022) Multilevel data integration and molecular docking approach to systematically elucidate the underlying pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma. Aging (Albany NY) 14:8783\u20138804","journal-title":"Aging (Albany NY)"},{"key":"3123_CR83","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523","journal-title":"Nat Commun"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03123-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T09:04:27Z","timestamp":1727946267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03123-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3123"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03123-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4239916\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}